» Articles » PMID: 38504720

Aortic Valve Cell Microenvironment: Considerations for Developing a Valve-on-chip

Overview
Specialty Biophysics
Date 2024 Mar 20
PMID 38504720
Authors
Affiliations
Soon will be listed here.
Abstract

Cardiac valves are sophisticated, dynamic structures residing in a complex mechanical and hemodynamic environment. Cardiac valve disease is an active and progressive disease resulting in severe socioeconomic burden, especially in the elderly. Valve disease also leads to a 50% increase in the possibility of associated cardiovascular events. Yet, valve replacement remains the standard of treatment with early detection, mitigation, and alternate therapeutic strategies still lacking. Effective study models are required to further elucidate disease mechanisms and diagnostic and therapeutic strategies. Organ-on-chip models offer a unique and powerful environment that incorporates the ease and reproducibility of systems along with the complexity and physiological recapitulation of the system. The key to developing effective valve-on-chip models is maintaining the cell and tissue-level microenvironment relevant to the study application. This review outlines the various components and factors that comprise and/or affect the cell microenvironment that ought to be considered while constructing a valve-on-chip model. This review also dives into the advancements made toward constructing valve-on-chip models with a specific focus on the aortic valve, that is, studies incorporating three-dimensional co-culture models that incorporate relevant extracellular matrices and mechanical and hemodynamic cues.

Citing Articles

Oxygenator assisted dynamic microphysiological culture elucidates the impact of hypoxia on valvular interstitial cell calcification.

Dittfeld C, Schmieder F, Behrens S, Jannasch A, Matschke K, Sonntag F J Biol Eng. 2024; 18(1):45.

PMID: 39180097 PMC: 11342540. DOI: 10.1186/s13036-024-00441-4.


A three-dimensional valve-on-chip microphysiological system implicates cell cycle progression, cholesterol metabolism and protein homeostasis in early calcific aortic valve disease progression.

Tandon I, Woessner A, Ferreira L, Shamblin C, Vaca-Diez G, Walls A Acta Biomater. 2024; 186:167-184.

PMID: 39084496 PMC: 11702842. DOI: 10.1016/j.actbio.2024.07.036.


Challenges of aortic valve tissue culture - maintenance of viability and extracellular matrix in the pulsatile dynamic microphysiological system.

Dittfeld C, Winkelkotte M, Scheer A, Voigt E, Schmieder F, Behrens S J Biol Eng. 2023; 17(1):60.

PMID: 37770970 PMC: 10538250. DOI: 10.1186/s13036-023-00377-1.

References
1.
Aikawa E, Whittaker P, Farber M, Mendelson K, Padera R, Aikawa M . Human semilunar cardiac valve remodeling by activated cells from fetus to adult: implications for postnatal adaptation, pathology, and tissue engineering. Circulation. 2006; 113(10):1344-52. DOI: 10.1161/CIRCULATIONAHA.105.591768. View

2.
Rodriguez K, Piechura L, Masters K . Regulation of valvular interstitial cell phenotype and function by hyaluronic acid in 2-D and 3-D culture environments. Matrix Biol. 2010; 30(1):70-82. PMC: 3021089. DOI: 10.1016/j.matbio.2010.09.001. View

3.
Benton J, DeForest C, Vivekanandan V, Anseth K . Photocrosslinking of gelatin macromers to synthesize porous hydrogels that promote valvular interstitial cell function. Tissue Eng Part A. 2009; 15(11):3221-30. PMC: 2783792. DOI: 10.1089/ten.TEA.2008.0545. View

4.
Ma Q, Ma H, Xu F, Wang X, Sun W . Microfluidics in cardiovascular disease research: state of the art and future outlook. Microsyst Nanoeng. 2021; 7:19. PMC: 8433381. DOI: 10.1038/s41378-021-00245-2. View

5.
Tandon I, Razavi A, Ravishankar P, Walker A, Sturdivant N, Lam N . Valve interstitial cell shape modulates cell contractility independent of cell phenotype. J Biomech. 2016; 49(14):3289-3297. DOI: 10.1016/j.jbiomech.2016.08.013. View